Breaking News Instant updates and real-time market news.

BIIB

Biogen

$223.57 /

+3.52 (+1.60%)

06:36
10/22/19
10/22
06:36
10/22/19
06:36

Biogen to offer access to aducanumab to patients enrolled in Phase 3 studies

  • 22

    Oct

BIIB Biogen
$223.57 /

+3.52 (+1.60%)

10/16/19 BofA
Biogen reinstated with an Underperform at BofA/Merrill
10/16/19 Morgan Stanley
Biogen deadline to settle Tecfidera IPR challenge nearing, says Morgan Stanley
10/04/19 Guggenheim
Guggenheim positively biased on Biotech heading into earnings
09/16/19 RBC Capital
Biogen Phase II study of BG00011 discontinued due to toxicity, says RBC Capital

TODAY'S FREE FLY STORIES

Hot Stocks
CME Group reports July average daily volume of 13.6M contracts » 07:35
08/04/20
08/04
07:35
08/04/20
07:35
CME

CME Group

$163.00 /

-3.18 (-1.91%)

Open interest at the end…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CME CME Group
$163.00 /

-3.18 (-1.91%)

CME CME Group
$163.00 /

-3.18 (-1.91%)

07/30/20 Deutsche Bank
CME Group price target lowered to $178 from $196 at Deutsche Bank
07/06/20 Wells Fargo
CME Group price target lowered to $176 from $186 at Wells Fargo
06/24/20 JPMorgan
CME Group shares could continue to underperform, says JPMorgan
06/23/20 Credit Suisse
CME Group price target lowered to $183 from $190 at Credit Suisse
CME CME Group
$163.00 /

-3.18 (-1.91%)

CME CME Group
$163.00 /

-3.18 (-1.91%)

CME CME Group
$163.00 /

-3.18 (-1.91%)

Hot Stocks
Sonnet BioTherapeutics enters LOI for SON-081, SON-080 license agreements » 07:35
08/04/20
08/04
07:35
08/04/20
07:35
SONN

Sonnet BioTherapeutics

$3.50 /

-0.65 (-15.66%)

Sonnet BioTherapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SONN Sonnet BioTherapeutics
$3.50 /

-0.65 (-15.66%)

SONN Sonnet BioTherapeutics
$3.50 /

-0.65 (-15.66%)

06/05/20 Chardan
Sonnet BioTherapeutics initiated with a Buy at Chardan
SONN Sonnet BioTherapeutics
$3.50 /

-0.65 (-15.66%)

Options
Unusual call flow in option market yesterday » 07:35
08/04/20
08/04
07:35
08/04/20
07:35
PINS

Pinterest

$36.07 /

+1.775 (+5.18%)

Notable call activity was…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PINS Pinterest
$36.07 /

+1.775 (+5.18%)

PINS Pinterest
$36.07 /

+1.775 (+5.18%)

08/03/20
Fly Intel: Top five analyst upgrades
08/03/20 Wedbush
Pinterest price target raised to $39 from $31 at Wedbush
08/03/20 DA Davidson
Pinterest price target raised to $28 from $19 at DA Davidson
08/03/20 JPMorgan
Pinterest price target raised to $37 from $26 at JPMorgan
PINS Pinterest
$36.07 /

+1.775 (+5.18%)

  • 16
    Oct
PINS Pinterest
$36.07 /

+1.775 (+5.18%)

PINS Pinterest
$36.07 /

+1.775 (+5.18%)

PINS Pinterest
$36.07 /

+1.775 (+5.18%)

Hot Stocks
Resideo sees net benefits of $30M-$40M in 2020 from F&O review » 07:34
08/04/20
08/04
07:34
08/04/20
07:34
REZI

Resideo

$11.15 /

-2.135 (-16.08%)

During the second…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
REZI Resideo
$11.15 /

-2.135 (-16.08%)

REZI Resideo
$11.15 /

-2.135 (-16.08%)

06/08/20 Imperial Capital
Resideo price target raised to $10 from $6 at Imperial Capital
04/28/20 Imperial Capital
Resideo downgraded to In-Line from Outperform at Imperial Capital
04/03/20
Fly Intel: Top five analyst initiations
04/03/20 Roth Capital
Resideo initiated with a Neutral at Roth Capital
REZI Resideo
$11.15 /

-2.135 (-16.08%)

Upgrade
Altice USA upgraded to Buy from Hold at TD Securities » 07:34
08/04/20
08/04
07:34
08/04/20
07:34
ATUS

Altice USA

$27.26 /

+0.27 (+1.00%)

TD Securities analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ATUS Altice USA
$27.26 /

+0.27 (+1.00%)

ATUS Altice USA
$27.26 /

+0.27 (+1.00%)

08/03/20 Deutsche Bank
Altice USA price target raised to $40 from $34 at Deutsche Bank
08/03/20 UBS
Charter price target raised to $650 from $575 at UBS
07/15/20 HSBC
Altice USA upgraded to Buy from Hold at HSBC
06/26/20 Nomura Instinet
Comcast 'green shoots' are emerging, says Nomura Instinet
ATUS Altice USA
$27.26 /

+0.27 (+1.00%)

  • 23
    Jun
  • 06
    May
  • 11
    Sep
  • 16
    Aug
ATUS Altice USA
$27.26 /

+0.27 (+1.00%)

ATUS Altice USA
$27.26 /

+0.27 (+1.00%)

Recommendations
Global Payments price target raised to $212 from $191 at Guggenheim » 07:34
08/04/20
08/04
07:34
08/04/20
07:34
GPN

Global Payments

$179.12 /

+1.39 (+0.78%)

Guggenheim analyst Jeff…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GPN Global Payments
$179.12 /

+1.39 (+0.78%)

GPN Global Payments
$179.12 /

+1.39 (+0.78%)

08/03/20 KeyBanc
Global Payments price target raised to $200 from $185 at KeyBanc
07/22/20 Barclays
Fiserv shares undervalued after 'clearing event,' says Barclays
07/14/20 Goldman Sachs
Global Payments initiated with a Buy at Goldman Sachs
06/29/20 Oppenheimer
Global Payments price target raised to $202 from $190 at Oppenheimer
GPN Global Payments
$179.12 /

+1.39 (+0.78%)

GPN Global Payments
$179.12 /

+1.39 (+0.78%)

Hot Stocks
Neuronetics sees FY20 operating expenses $58M-$60M » 07:34
08/04/20
08/04
07:34
08/04/20
07:34
STIM

Neuronetics

$2.72 /

+0.05 (+1.87%)

Currently, the Company is…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
STIM Neuronetics
$2.72 /

+0.05 (+1.87%)

STIM Neuronetics
$2.72 /

+0.05 (+1.87%)

07/14/20 Piper Sandler
Investors should take 'fresh look' at Neuronetics after CEO hire, says Piper
05/05/20 William Blair
William Blair downgrades Neuronetics on restructuring uncertainty
05/05/20 William Blair
Neuronetics downgraded to Market Perform from Outperform at William Blair
05/05/20 Piper Sandler
Neuronetics' COVID-19 response measures the right decision, says Piper
STIM Neuronetics
$2.72 /

+0.05 (+1.87%)

Earnings
Spirit AeroSystems reports Q2 adjusted EPS ($2.28), consensus ($1.33) » 07:33
08/04/20
08/04
07:33
08/04/20
07:33
SPR

Spirit AeroSystems

$19.50 /

-0.05 (-0.26%)

Reports Q2 revenue $645M,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SPR Spirit AeroSystems
$19.50 /

-0.05 (-0.26%)

SPR Spirit AeroSystems
$19.50 /

-0.05 (-0.26%)

07/08/20 Bernstein
Bernstein downgrades Spirit AeroSystems on slower delivery recovery
07/08/20 Bernstein
Spirit AeroSystems downgraded to Market Perform from Outperform at Bernstein
06/26/20 RBC Capital
Spirit AeroSystems initiated with an Outperform at RBC Capital
06/23/20
Fly Intel: Top five analyst downgrades
SPR Spirit AeroSystems
$19.50 /

-0.05 (-0.26%)

SPR Spirit AeroSystems
$19.50 /

-0.05 (-0.26%)

SPR Spirit AeroSystems
$19.50 /

-0.05 (-0.26%)

SPR Spirit AeroSystems
$19.50 /

-0.05 (-0.26%)

Earnings
Resideo reports Q2 adjusted EPS 17c, consensus 4c » 07:33
08/04/20
08/04
07:33
08/04/20
07:33
REZI

Resideo

$11.15 /

-2.135 (-16.08%)

Reports Q2 revenue $1B,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
REZI Resideo
$11.15 /

-2.135 (-16.08%)

REZI Resideo
$11.15 /

-2.135 (-16.08%)

06/08/20 Imperial Capital
Resideo price target raised to $10 from $6 at Imperial Capital
04/28/20 Imperial Capital
Resideo downgraded to In-Line from Outperform at Imperial Capital
04/03/20
Fly Intel: Top five analyst initiations
04/03/20 Roth Capital
Resideo initiated with a Neutral at Roth Capital
REZI Resideo
$11.15 /

-2.135 (-16.08%)

Recommendations
SolarEdge price target raised to $207 from $151 » 07:33
08/04/20
08/04
07:33
08/04/20
07:33
SEDG

SolarEdge

$173.52 /

-1.36 (-0.78%)

Oppenheimer analyst Colin…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SEDG SolarEdge
$173.52 /

-1.36 (-0.78%)

SEDG SolarEdge
$173.52 /

-1.36 (-0.78%)

08/03/20 JMP Securities
SolarEdge downgraded to Market Perform from Outperform at JMP Securities
08/03/20 JMP Securities
SolarEdge downgraded to Market Perform from Outperform at JMP Securities
07/27/20 Roth Capital
SolarEdge price target raised to $190 from $140 at Roth Capital
06/24/20 Goldman Sachs
SolarEdge downgraded to Sell from Neutral at Goldman Sachs
SEDG SolarEdge
$173.52 /

-1.36 (-0.78%)

SEDG SolarEdge
$173.52 /

-1.36 (-0.78%)

SEDG SolarEdge
$173.52 /

-1.36 (-0.78%)

Earnings
Neuronetics reports Q2 EPS (41c), consensus (51c) » 07:32
08/04/20
08/04
07:32
08/04/20
07:32
STIM

Neuronetics

$2.72 /

+0.05 (+1.87%)

Reports Q2 revenue $9.7M,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
STIM Neuronetics
$2.72 /

+0.05 (+1.87%)

STIM Neuronetics
$2.72 /

+0.05 (+1.87%)

07/14/20 Piper Sandler
Investors should take 'fresh look' at Neuronetics after CEO hire, says Piper
05/05/20 William Blair
William Blair downgrades Neuronetics on restructuring uncertainty
05/05/20 William Blair
Neuronetics downgraded to Market Perform from Outperform at William Blair
05/05/20 Piper Sandler
Neuronetics' COVID-19 response measures the right decision, says Piper
STIM Neuronetics
$2.72 /

+0.05 (+1.87%)

Hot Stocks
Eros International provides update on STX Entertainment merger, financings » 07:32
08/04/20
08/04
07:32
08/04/20
07:32
EROS

Eros International

$2.89 /

+0.055 (+1.94%)

Eros announced that its…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
EROS Eros International
$2.89 /

+0.055 (+1.94%)

EROS Eros International
$2.89 /

+0.055 (+1.94%)

EROS Eros International
$2.89 /

+0.055 (+1.94%)

Earnings
Vulcan Materials not reinstating FY20 guidance at this time » 07:32
08/04/20
08/04
07:32
08/04/20
07:32
VMC

Vulcan Materials

$117.87 /

+0.42 (+0.36%)

Regarding the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
VMC Vulcan Materials
$117.87 /

+0.42 (+0.36%)

VMC Vulcan Materials
$117.87 /

+0.42 (+0.36%)

07/10/20 SunTrust
Vulcan Materials price target raised to $145 from $125 at SunTrust
06/22/20 Loop Capital
Vulcan Materials, Martin Marietta price targets raised at Loop Capital
06/19/20 Atlantic Equities
Atlantic Equities starts Vulcan Materials at Overweight, sees faster growth
06/19/20 Atlantic Equities
Vulcan Materials initiated with an Overweight at Atlantic Equities
VMC Vulcan Materials
$117.87 /

+0.42 (+0.36%)

VMC Vulcan Materials
$117.87 /

+0.42 (+0.36%)

VMC Vulcan Materials
$117.87 /

+0.42 (+0.36%)

VMC Vulcan Materials
$117.87 /

+0.42 (+0.36%)

Recommendations
Ansys price target raised to $350 from $278 at Guggenheim » 07:31
08/04/20
08/04
07:31
08/04/20
07:31
ANSS

Ansys

$315.10 /

+5.12 (+1.65%)

Guggenheim analyst Ken…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ANSS Ansys
$315.10 /

+5.12 (+1.65%)

ANSS Ansys
$315.10 /

+5.12 (+1.65%)

03/13/20 Wedbush
Ansys price target lowered to $249 from $295 at Wedbush
02/19/20 Baird
Ansys assumed with an Outperform at Baird
02/10/20 Citi
Ansys downgraded to Neutral from Buy at Citi (Friday)
02/07/20 Citi
Ansys downgraded to Neutral from Buy at Citi
ANSS Ansys
$315.10 /

+5.12 (+1.65%)

Downgrade
Sonoco downgraded to Hold from Buy at Argus » 07:31
08/04/20
08/04
07:31
08/04/20
07:31
SON

Sonoco

$52.29 /

+0.71 (+1.38%)

Argus analyst David…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SON Sonoco
$52.29 /

+0.71 (+1.38%)

SON Sonoco
$52.29 /

+0.71 (+1.38%)

07:21 Today Argus
Sonoco downgraded to Hold from Buy at Argus
05/21/20 Wells Fargo
Sonoco upgraded to Overweight on favorable price/cost at Wells Fargo
05/21/20 Wells Fargo
Sonoco upgraded to Overweight from Equal Weight at Wells Fargo
04/22/20 Argus
Sonoco upgraded to Buy from Hold at Argus
SON Sonoco
$52.29 /

+0.71 (+1.38%)

Earnings
Vulcan Materials reports Q2 adj. cont ops EPS $1.60, consensus $1.38 » 07:30
08/04/20
08/04
07:30
08/04/20
07:30
VMC

Vulcan Materials

$117.87 /

+0.42 (+0.36%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
VMC Vulcan Materials
$117.87 /

+0.42 (+0.36%)

VMC Vulcan Materials
$117.87 /

+0.42 (+0.36%)

07/10/20 SunTrust
Vulcan Materials price target raised to $145 from $125 at SunTrust
06/22/20 Loop Capital
Vulcan Materials, Martin Marietta price targets raised at Loop Capital
06/19/20 Atlantic Equities
Atlantic Equities starts Vulcan Materials at Overweight, sees faster growth
06/19/20 Atlantic Equities
Vulcan Materials initiated with an Overweight at Atlantic Equities
VMC Vulcan Materials
$117.87 /

+0.42 (+0.36%)

VMC Vulcan Materials
$117.87 /

+0.42 (+0.36%)

VMC Vulcan Materials
$117.87 /

+0.42 (+0.36%)

VMC Vulcan Materials
$117.87 /

+0.42 (+0.36%)

Earnings
Henry Schein not providing FY20 guidance at this time » 07:30
08/04/20
08/04
07:30
08/04/20
07:30
HSIC

Henry Schein

$70.90 /

+2.18 (+3.17%)

Henry Schein said in its…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
HSIC Henry Schein
$70.90 /

+2.18 (+3.17%)

HSIC Henry Schein
$70.90 /

+2.18 (+3.17%)

05/06/20 Barrington
Henry Schein downgraded to Market Perform from Outperform at Barrington
04/07/20 Goldman Sachs
Henry Schein upgraded to Buy from Neutral at Goldman Sachs
04/02/20 Wolfe Research
Henry Schein upgraded to Outperform from Peer Perform at Wolfe Research
02/07/20 Cleveland Research
Large dental manufacturer seen exploring direct move, says Cleveland Research
HSIC Henry Schein
$70.90 /

+2.18 (+3.17%)

HSIC Henry Schein
$70.90 /

+2.18 (+3.17%)

Earnings
Inphi sees Q3 EPS 83c-87c, consensus 68c  07:30
08/04/20
08/04
07:30
08/04/20
07:30
IPHI

Inphi

$135.11 /

+4.515 (+3.46%)

 
ShowHide Related Items >><<
IPHI Inphi
$135.11 /

+4.515 (+3.46%)

IPHI Inphi
$135.11 /

+4.515 (+3.46%)

07/23/20 Loop Capital
Inphi initiated with a Buy at Loop Capital
07/17/20 Deutsche Bank
Inphi price target raised to $140 from $115 at Deutsche Bank
07/07/20 Needham
Inphi price target raised to $135 from $122.50 at Needham
06/25/20 JPMorgan
Inphi datacenter business can grow 30% annually, says JPMorgan
IPHI Inphi
$135.11 /

+4.515 (+3.46%)

IPHI Inphi
$135.11 /

+4.515 (+3.46%)

Earnings
Henry Schein reports Q2 EPS 0c, consensus (12c) » 07:30
08/04/20
08/04
07:30
08/04/20
07:30
HSIC

Henry Schein

$70.90 /

+2.18 (+3.17%)

Reports Q2 revenue $1.7B,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
HSIC Henry Schein
$70.90 /

+2.18 (+3.17%)

HSIC Henry Schein
$70.90 /

+2.18 (+3.17%)

05/06/20 Barrington
Henry Schein downgraded to Market Perform from Outperform at Barrington
04/07/20 Goldman Sachs
Henry Schein upgraded to Buy from Neutral at Goldman Sachs
04/02/20 Wolfe Research
Henry Schein upgraded to Outperform from Peer Perform at Wolfe Research
02/07/20 Cleveland Research
Large dental manufacturer seen exploring direct move, says Cleveland Research
HSIC Henry Schein
$70.90 /

+2.18 (+3.17%)

HSIC Henry Schein
$70.90 /

+2.18 (+3.17%)

Earnings
Inphi sees Q3 revenue $179M-$182.5M, consensus $156.3M  07:30
08/04/20
08/04
07:30
08/04/20
07:30
IPHI

Inphi

$135.11 /

+4.515 (+3.46%)

 
ShowHide Related Items >><<
IPHI Inphi
$135.11 /

+4.515 (+3.46%)

IPHI Inphi
$135.11 /

+4.515 (+3.46%)

07/23/20 Loop Capital
Inphi initiated with a Buy at Loop Capital
07/17/20 Deutsche Bank
Inphi price target raised to $140 from $115 at Deutsche Bank
07/07/20 Needham
Inphi price target raised to $135 from $122.50 at Needham
06/25/20 JPMorgan
Inphi datacenter business can grow 30% annually, says JPMorgan
IPHI Inphi
$135.11 /

+4.515 (+3.46%)

IPHI Inphi
$135.11 /

+4.515 (+3.46%)

Hot Stocks
Incyte provides update on parsaclisib with ruxolitinib data » 07:29
08/04/20
08/04
07:29
08/04/20
07:29
INCY

Incyte

$101.84 /

+3.08 (+3.12%)

Positive proof-of-concept…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
INCY Incyte
$101.84 /

+3.08 (+3.12%)

INCY Incyte
$101.84 /

+3.08 (+3.12%)

08/03/20 Deutsche Bank
MorphoSys FDA approval in line with expectations, says Deutsche Bank
08/03/20 Piper Sandler
Monjuvi U.S. launch a solid long-term contributor for Incyte, says Piper Sandler
07/23/20 Stifel
Incyte REACH3 'nice incremental surprise,' not narrative-changing, says Stifel
07/23/20 Piper Sandler
Piper says Incyte cements 'all-around win for Jakafi' with REACH3 results
INCY Incyte
$101.84 /

+3.08 (+3.12%)

INCY Incyte
$101.84 /

+3.08 (+3.12%)

INCY Incyte
$101.84 /

+3.08 (+3.12%)

Earnings
Inphi reports Q2 EPS 95c, consensus 65c » 07:29
08/04/20
08/04
07:29
08/04/20
07:29
IPHI

Inphi

$135.11 /

+4.515 (+3.46%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
IPHI Inphi
$135.11 /

+4.515 (+3.46%)

IPHI Inphi
$135.11 /

+4.515 (+3.46%)

07/23/20 Loop Capital
Inphi initiated with a Buy at Loop Capital
07/17/20 Deutsche Bank
Inphi price target raised to $140 from $115 at Deutsche Bank
07/07/20 Needham
Inphi price target raised to $135 from $122.50 at Needham
06/25/20 JPMorgan
Inphi datacenter business can grow 30% annually, says JPMorgan
IPHI Inphi
$135.11 /

+4.515 (+3.46%)

IPHI Inphi
$135.11 /

+4.515 (+3.46%)

Upgrade
Wendy's upgraded to Buy from Neutral at Kalinowski » 07:29
08/04/20
08/04
07:29
08/04/20
07:29
WEN

Wendy's

$23.03 /

-0.16 (-0.69%)

Kalinowski upgraded…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
WEN Wendy's
$23.03 /

-0.16 (-0.69%)

WEN Wendy's
$23.03 /

-0.16 (-0.69%)

07/27/20 Stephens
McDonald's, Domino's among restaurant stocks to own now, says Stephens
06/24/20 JPMorgan
Wendy's price target raised to $23 from $21 at JPMorgan
06/09/20 BMO Capital
Wendy's price target raised to $26 from $23 at BMO Capital
06/05/20 Longbow
Wendy's domestic comps have returned to positive growth, says Longbow
WEN Wendy's
$23.03 /

-0.16 (-0.69%)

WEN Wendy's
$23.03 /

-0.16 (-0.69%)

WEN Wendy's
$23.03 /

-0.16 (-0.69%)

WEN Wendy's
$23.03 /

-0.16 (-0.69%)

Recommendations
TikTok presents 'unique opportunity' for Microsoft, says Oppenheimer » 07:28
08/04/20
08/04
07:28
08/04/20
07:28
MSFT

Microsoft

$216.60 /

+11.605 (+5.66%)

Oppenheimer analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MSFT Microsoft
$216.60 /

+11.605 (+5.66%)

MSFT Microsoft
$216.60 /

+11.605 (+5.66%)

08/03/20 Wedbush
Wedbush sees a TikTok deal as big bet from Microsoft on social media space
07/31/20 Stifel
Citrix disclosure points to $1B commitment, most likely to Azure, says Stifel
07/27/20 Morgan Stanley
Morgan Stanley downgrades Software industry view to In-Line from Attractive
07/23/20
Fly Intel: Top five analyst downgrades
MSFT Microsoft
$216.60 /

+11.605 (+5.66%)

MSFT Microsoft
$216.60 /

+11.605 (+5.66%)

MSFT Microsoft
$216.60 /

+11.605 (+5.66%)

MSFT Microsoft
$216.60 /

+11.605 (+5.66%)

MSFT Microsoft
$216.60 /

+11.605 (+5.66%)

Recommendations
AMD price target raised to $95 from $86 at Jefferies » 07:28
08/04/20
08/04
07:28
08/04/20
07:28
AMD

AMD

$77.65 /

+0.23 (+0.30%)

, INTC

Intel

$48.29 /

+0.57 (+1.19%)

Jefferies analyst Mark…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AMD AMD
$77.65 /

+0.23 (+0.30%)

INTC Intel
$48.29 /

+0.57 (+1.19%)

AMD AMD
$77.65 /

+0.23 (+0.30%)

07/29/20
Fly Intel: Top five analyst downgrades
07/29/20
Fly Intel: Top five analyst upgrades
07/29/20 JPMorgan
AMD price target raised to $62 from $52 at JPMorgan
07/29/20 Exane BNP Paribas
AMD upgraded to Outperform from Neutral at Exane BNP Paribas
INTC Intel
$48.29 /

+0.57 (+1.19%)

08/03/20 Roth Capital
MaxLinear price target raised to $35 from $30 at Roth Capital
08/03/20 Stifel
Stifel rises MaxLinear price target to $35 after completion of Home Gateway deal
07/31/20 Erste
Intel downgraded to Hold from Buy at Erste
07/29/20 Wells Fargo
AMD price target raised to $72 from $55 at Wells Fargo
AMD AMD
$77.65 /

+0.23 (+0.30%)

INTC Intel
$48.29 /

+0.57 (+1.19%)

AMD AMD
$77.65 /

+0.23 (+0.30%)

INTC Intel
$48.29 /

+0.57 (+1.19%)

AMD AMD
$77.65 /

+0.23 (+0.30%)

INTC Intel
$48.29 /

+0.57 (+1.19%)

AMD AMD
$77.65 /

+0.23 (+0.30%)

INTC Intel
$48.29 /

+0.57 (+1.19%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.